September 13, 2019
4,959
81
9
1.81%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
4:36Now PlayingThe Scottish government has struck an agreement with a pharmaceutical company to make two "life-changing" cystic fibrosis (CF) drugs available to patients in Scotland.
Subscribe to our channel here
The five-year agreement has been reached with pharmaceutical company Vertex over the use of Orkambi and Symkevi. The drugs improve lung health but were rejected for NHS use in August 2019 because they were not deemed cost-effective.
The medication normally costs £100,000 per patient, per year. The Scottish government said it had secured a "confidential discount" from the manufacturer.
Patients in other parts of the UK are still not able to access the treatment, with campaigners calling for an end to the "postcode lottery".
In June, Deborah Cohen met up with patients and their parents who were banding together to import generic copies of CF drugs.Now, Deborah speaks to the parents who have travelled 7,000 miles to Argentina to buy a cheaper version of the medicine.
Newsnight is the BBC's flagship news and current affairs TV programme - with analysis, debate, exclusives, and robust interviews.
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.